| Product Name | Bortezomib-D8 (Major) |
| Product Code | DA-B169-58 |
| Chemical name | Bortezomib-D8 (Major) |
| Synonyms | Velcade-D8, [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic Acid-D8; |
| Impurity | NA |
| CAS Number | NA |
| Alternate CAS # | NA |
| Molecular form | C19H17D8BN4O4 |
| Appearance | Off-White to Pale Yellow Solid |
| Melting Point | NA |
| Mol. Weight | 392.29 |
| Storage | 2-8°C Refrigerator, Under Inert Atmosphere |
| Solubility | NA |
| Stability | NA |
| Category | chiral standards,boron derivatives,enzyme inhibitors,pharmaceutical standards,intermediates,Fine Chemicals,stable isotopes |
| Boiling Point | NA |
| Applications | Labelled Bortezomib, whcih the first proteasome inhibitor to be approved b the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. d6-3% d7-10% d8-86% |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
